Problem-Solving Therapy and Supportive Therapy in Older Adults With Major Depression and Executive Dysfunction
Open accessAbstract
OBJECTIVE: The purpose of this study was to determine whether problem-solving therapy is an effective treatment in older patients with depression and executive dysfunction, a population likely to be resistant to antidepressant drugs. METHOD: Participants were adults age 60 and older with major depression and executive dysfunction. Problem-solving therapy was modified to be accessible to this population. Participants were randomly assigned to 12 weekly sessions of problem-solving therapy or supportive therapy and assessed at weeks 3, 6, 9, and 12. RESULTS: Of the 653 individuals referred for this study, 221 met selection criteria and were enrolled in the study. Reduction of depressive symptom severity was comparable for the two treatment groups during the first 6 weeks of treatment, but at weeks 9 and 12 the problem-solving therapy group had a greater reduction in symptom severity, a greater response rate, and a greater remission rate than the supportive therapy group (response rates at week 9: 47.1% and 29.3%; at week 12:56.7% and 34.0%; remission rates at week 9: 37.9% and 21.7%; at week 12: 45.6% and 27.8%). Problem-solving therapy yielded one additional response or remission over supportive therapy for every 4.4-5.6 patients by the end of the trial. CONCLUSIONS: These results suggest that problem-solving therapy is effective in reducing depressive symptoms and leading to treatment response and remission in a considerable number of older patients with major depression and executive dysfunction. The clinical value of this finding is that problem-solving therapy may be a treatment alternative in an older patient population likely to be resistant to pharmacotherapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Problem solving therapy was more effective than supportive therapy in reducing depression and disability in older adults with DED.
“Problem solving therapy was more effective that supportive therapy in reducing depression and disability in older adults with DED162,163, a syndrome with poor response to antidepressants32–38,164.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 40 · Cited by 275
Research works printed but not linked: 1
- [25]Epping-Jordan JA Ustun TB The WHODAS-II: leveling the playing field for all disorders World Health Organization Mental Health Bulletin 2000 6 5 6
- Authors
- Areán, P. A., Raue, P., Mackin, R. S., Kanellopoulos, D., McCulloch, C., & Alexopoulos, G. S.
- Affiliations
- University of California, San Francisco (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2010-11
- Volume
- 167
- Issue
- 11
- Pages
- 1391-1398
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC2998516
- OpenAlex
- W2150957352
- Cited by
- 275
- References
- 40
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 3 · 2023: 6 · 2022: 16 · 2021: 11 · 2020: 25 · 2019: 10 · 2018: 20 · 2017: 24 · 2016: 12 · 2015: 31 · 2014: 30 · 2013: 30 · 2012: 18
- FWCI
- 23.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Institute of Mental Health (R01MH075897, P30MH085943, R01MH064099, K24MH074717, R01MH063982)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- problem-solving therapy, supportive therapy, major depressive disorder, older adults, executive dysfunction, antidepressant resistance, depression severity, treatment response, remission, psychotherapy for depression
- MeSH terms
- Aged, Cognition Disorders, Depressive Disorder, Major, Major Depressive Disorder, Disability Evaluation, Female, Follow-Up Studies, Humans, Male, Mental Status Schedule, Middle Aged, Neuropsychological Tests, Person-Centered Psychotherapy, Personality Inventory, Psychotherapy, Recurrence, Social Support, Executive Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review